|

Treatment Options and Risk Assessment
Second Edition
Edited
By
Christof Schaefer, Teratology
Information Unit Berlin, Beratungsstelle Embryotoxikologie, Berlin,
Germany
Paul W.J. Peters, Department of
Obstetrics, Division of Perinatology and Gynecology, University Medical
Centre Utrecht, The Netherlands
Richard K Miller, Teratogen
Information Center, Univ. of Rochester, Dept Obstetrics and Gynecology,
NY, U.S.A.
Description
The latest edition is the
resource for any practicing OB/GYN, family physician, midwife, or
pharmacist who prescribes medicinal products to or evaluates
environmental or occupational exposures in women who are or may become
pregnant. Based on the highly successful seven German editions of this
reference, the up-to-date drug listings have been revised into a handy
pocket guide color tabbed for quick access to important information.
Easy to reference each drug is listed discussing the side effects,
general impact on organ systems, potential toxicity, and risks before
offering dosage recommendations. It is the only book of its kind to
provide conclusive information on treatments for diseases during
pregnancy and lactation and actions to be taken after (inadvertant)
exposure to drugs suspected to be developmentaly toxic. Unlike other
dosage guides, this edition is an affordable, compact compendium of
knowledge on the very latest drugs and their effects on
pregnant/lactating women.
Audience
Obstetricians and Gynecologists; Breast feeding specialists, Nursing
practitioners
Contents
Preface List of Contributors
1. General commentary to drug therapy and
drug risks in pregnancy
Richard K. Miller, Paul W. Peters and Christof E. Schaefer
2. Specific drug therapies during pregnancy
2.1
Analgesics and Anti-Inflammatory Drugs Minke Reuvers, Christof Schaefer
2.2 Antiallergic Drugs and Desensitization Margreet Rost van Tonningen
2.3 Antiasthmatic and Cough Medication Hanneke Garbis 2.4 Antiemetics
Lee H Goldstein, Matitiahu Berkovitch 2.5 Gastrointestinal,
Antilipidemic Agents and Spasmolytics Margreet Rost van Tonningen 2.6
Anti-infective agents Hanneke Garbis, Margreet Rost van Tonningen,
Minke Reuvers 2.7 Vaccines and Immunoglobulins Paul Peters 2.8 Heart
and Circulatory System Drugs and Diuretics Corinna Weber-Schoendorfer
2.9 Anticoagulant and fibrinolytic drugs Minke Reuvers 2.10
Antiepileptics Elisabeth Robert-Gnansia, Christof Schaefer 2.11
Psychotropic drugs Hanneke Garbis, Patricia R. McElhatton
2.12.Immunomodulators Corinna Weber-Schoendorfer 2.13 Antineoplastic
Drugs Corinna Weber-Schoendorfer, Christof Schaefer 2.14 Uterine
contraction agents, tocolytics, vaginal therapeutics and local
contraceptives Herman van Geijn 2.15 Hormones Elvira Rodriguez-Pinilla,
Corinna Weber-Schoendorfer 2.16 General and local anesthetics and muscle
relaxants Asher Ornoy 2.17 Dermatological medications and local
therapeutics Paul Peters, Christof Schaefer 2.18 Vitamins, minerals and
trace elements Paul Peters, Christof Schaefer 2.19 Herbs During
Pregnancy Henry M. Hess, Richard K. Miller, 2.20 Diagnostic agents
Elisabeth Robert-Gnansia 2.21Recreational drugs Paul Peters Christof
Schaefer 2.22 Poisonings and Toxins Christof Schaefer 2.23
Occupational, industrial and environmental agents Paul Peters, Richard
K. Miller and Patricia R. McElhatton
3 General Commentary on Drug Therapy and
Drug Risk During Lactation
Ruth Lawrence, Christof Schaefer
4 Specific drug therapies during lactation
4.1
Analgesics, antiphlogistics and anesthetics Christof Schaefer 4.2
Antiallergics, antiasthmatics and antitussives Christof Schaefer 4.3
Gastrointestinal drugs Christof Schaefer 4.4 Antiinfectives Christof
Schaefer 4.5 Vaccines and Immunoglobulins Ruth Lawrence, Christof
Schaefer 4.6 Cardiovascular drugs and diuretics Christof Schaefer 4.7
Anticoagulants and fibrinolytics Christof Schaefer 4.8 Antiepileptics
Christof Schaefer 4.9 Psychotropic drugs Christof Schaefer 4.10
Immunomodulating and Antineoplastic Agents Ruth Lawrence, Christof
Schaefer 4.11 Hormones and hormone antagonists Christof Schaefer 4.12
Dermatological Drugs and Local Therapeutics Ruth Lawrence, Christof
Schaefer 4.13 Alternative Remedies , Vitamins and Minerals Ruth
Lawrence, Christof Schaefer 4.14 Diagnostics Ruth Lawrence, Christof
Schaefer 4.15 Infections Ruth Lawrence, Christof Schaefer 4.16
Recreational Drugs Ruth Lawrence, Christof Schaefer 4.17 Plant Toxins
Ruth Lawrence, Christof Schaefer 4.18 Industrial chemicals and
environmental contaminants Christof Schaefer Appendix A - Teratology
Information Centers Appendix B - Addresses for breastfeeding support
Subject Index
Bibliographic
& ordering Information
Hardbound, 904 pages, publication date: JUN-2007
ISBN-13: 978-0-444-52072-2
ISBN-10: 0-444-52072-4
Imprint: ACADEMIC PRESS
Price:
EUR 41.95
USD 49.95
GBP 28.99
|
|
DRUGS DURING PREGNANCY AND
LACTATION
Handbook of prescription drugs and
comparative risk assessment
Edited by
C. Schaefer
Co-authors:
H. Garbis, P. McElhatton, P. Peters, M. Reuvers, E.
Robert, M. Rost van Tonningen, A. Scialli
ELSEVIER, AMSTERDAM 2001
ISBN: 0-444-50763-9
Description
The care
of pregnant women presents one of the paradoxes of modern medicine.
Women usually require little medical intervention during an
(uneventful) pregnancy. Conversely, those at high risk of damage to
their own health or that of their unborn require the help of
appropriate medicinal technology, including drugs. Accordingly, there
are two classes of pregnant women, the larger group requires support
but not much intervention, while the other needs the full range of
diagnostic and therapeutic measures applied in any other branch of
medicine.
This
book presents the current state of
knowledge about drugs in pregnancy. In each chapter information is
presented separately for two different aspects of the problem seeking a
drug appropriate for prescription during pregnancy, and assessing the
risk of a drug when exposure has already taken place.
Practising
clinicians who prescribe
medicinal products to women who are, or who may become, pregnant, will
find this volume an invaluable reference.
|